Dental Hygiene Clinicians Report September/October 2010, Volume 3 Issue 5

Quantity

Price $10.00 +Add to wishlist +Email Colleague

Your Name
Your Email
Friend's Name
Friend's Email
Your Message
Security Code	The security code helps us fight spam

Product Details

Articles In This Issue:

OraVerse—The First and Only Local Anesthesia Reversal Agent
Products Highly Rated in CR Clinical Trials

Companies

Novalar Pharmaceuticals
Oolitt Advantage

Brands

Oolitt Jr (Oolie)
OraVerse

Dental Hygiene Clinicians Report September/October 2010, Volume 3 Issue 5 - h201010

Abstract

OraVerse—The First and Only Local Anesthesia Reversal Agent

• What Is OraVerse?
• How Does OraVerse Work?
• What are the OraVerse Dosing Guidelines and Precautions?
• Who is OraVerse for?
• Advantages and Limitations
• Clinical Evaluation
• Clinical Results
• Clinical Survey Results
• CR Conclusions

Products Highly Rated in CR Clinical Trials

• Tongue Cleaner Specially Designed for Children and Patients with Small Oral Cavities

* Due to immediate access and download, purchase of past issues and single topic articles are non-refundable. CR is a non-profit, educational research institute. Your purchase funds this research.

Email
Password